Administration of β-lactam antibiotics and delivery method correlate with intestinal abundances of Bifidobacteria and Bacteroides in early infancy, in Japan

Sci Rep. 2021 Mar 18;11(1):6231. doi: 10.1038/s41598-021-85670-z.

Abstract

The intestinal microbiome changes dynamically in early infancy. Colonisation by Bifidobacterium and Bacteroides and development of intestinal immunity is interconnected. We performed a prospective observational cohort study to determine the influence of antibiotics taken by the mother immediately before delivery on the intestinal microbiome of 130 healthy Japanese infants. Faecal samples (383) were collected at 1, 3, and 6 months and analysed using next-generation sequencing. Cefazolin was administered before caesarean sections, whereas ampicillin was administered in cases with premature rupture of the membranes and in Group B Streptococcus-positive cases. Bifidobacterium and Bacteroides were dominant (60-70% mean combined occupancy) at all ages. A low abundance of Bifidobacterium was observed in infants exposed to antibiotics at delivery and at 1 and 3 months, with no difference between delivery methods. A lower abundance of Bacteroides was observed after caesarean section than vaginal delivery, irrespective of antibiotic exposure. Additionally, occupancy by Bifidobacterium at 1 and 3 months and by Bacteroides at 3 months differed between infants with and without siblings. All these differences disappeared at 6 months. Infants exposed to intrapartum antibiotics displayed altered Bifidobacterium abundance, whereas abundance of Bacteroides was largely associated with the delivery method. Existence of siblings also significantly influenced the microbiota composition of infants.

Publication types

  • Observational Study

MeSH terms

  • Ampicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Bacteroides / genetics*
  • Bacteroides / isolation & purification
  • Bifidobacterium / genetics*
  • Bifidobacterium / isolation & purification
  • Cefazolin / therapeutic use
  • Cesarean Section*
  • Delivery, Obstetric / methods
  • Feces / microbiology
  • Female
  • Gastrointestinal Microbiome / genetics*
  • Humans
  • Infant
  • Infant, Newborn
  • Intestines / microbiology
  • Japan
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / microbiology*
  • Prospective Studies
  • Siblings
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / microbiology*

Substances

  • Anti-Bacterial Agents
  • Ampicillin
  • Cefazolin

Associated data

  • figshare/10.6084/m9.figshare.12000255